Carboplatin-gemcitabine in the treatment of elderly patients with non-small cell lung cancer: An outcome analysis
Journal Title: Journal of Cancer Research & Therapy - Year 2015, Vol 3, Issue 10
Abstract
Introduction: To compare a novel carboplatin-gemcitabine (CG) schedule with gemcitabine (G) monochemotherapy in elderly patients with advanced NSCLC. Methods: The records of all the consecutive elderly patients referred to our Department of Oncology for advanced NSCLC were reviewed. Overall survival was the main outcome, time to progression, response rate and safety were the secondary end points. Results: Fifty patients (40 males and 10 females, mean age 75 years, range 68-87 years) were included into the analysis. 30 patients (60%) were treated with the CG and 20 (40%) with G. Median survival was 12.4 months for the entire population, and 14.9 and 5.3 months for CG and G(p=0.043) respectively. 7(14%) and 2(4%) partial regressions were observed in CG and G groups,(p=0.085), with a median time to progression of 5.1 months for the entire population, and 7.3 and 3.5 months for CG and G(p=0.237). Grade III neutropenia was observed in 8(16%) and 2(4%) patients treated with CG and G, respectively; grade IV neutropenia in 2(4%) and 2(4%) patients, grade III anemia in 2(4%) and 1(2%) patients, and grade III thrombocytopenia in 1(2) patient, respectively (p=0.527). Grade II fatigue was observed in 5(10%) and 2(4%) patients, grade III diarrhea in 3(6%) and 1(2%) patients treated with CG and G, respectively (p=0.722). Conclusions: Carboplatin-gemcitabine seems to be more effective that gemcitabine alone in elderly patients with advanced NSCLC, without any worsening of the safety profile. The data, extracted from an outcome analysis, confirm what has been observed in previous clinical trials.
Authors and Affiliations
Fantini M, Stocchi L, Affatato A, Papi M, Sartori S, Ioli G, Lazzari-Agli L, Tassinari D
Keywords
Related Articles
- EP ID EP546095
- DOI 10.14312/2052-4994.2015-16
- Views 73
- Downloads 0
A review of electrophoretic patterns from a tertiary care nephrourology referral centre
Protein electrophoresis is an easy, inexpensive test routinely used in clinical laboratories for screening protein abnormalities in various biological fluids. It is commonly used test to identify patients with multiple m...
Changing trends in gastrointestinal malignancy in Indonesia: The Jakarta experience
Aims: To identify changing trends in gastrointestinal cancer incidence in Indonesia according to age, gender, histopathology, and cancer location. Methods: We examined retrospectively the demography, cancer location, and...
Characterizing tobacco use in an American cancer center’s catchment area can help direct future research priorities
Purpose: American cancer centers supported by the National Cancer Institute (NCI) must ensure that their research addresses the cancer relevant needs and risks of members of their catchment area. In 2016, the NCI support...
Synergistic antineoplastic action of 5-aza-2'deoxycytidine (decitabine) in combination with different inhibitors of enhancer of zeste homolog 2 (EZH2) on human lung carcinoma cells
Patients with metastatic lung cancer have a very poor prognosis indicating an urgent need to develop more effective chemotherapy. Aberrant promoter DNA methylation can result in the epigenetic silencing of tumor suppress...
In vitro and in vivo evaluation of tubulin inhibitors with non-small cell lung cancer pre-clinical models
Synthetic small molecule tubulin inhibitors have many advantages as novel anti-cancer agents compared to the current tubulin inhibitors generated from natural products. Our previous studies led to the design and synthesi...